Adipose tissue-derived stem cells show both immunogenic and immunosuppressive properties after chondrogenic differentiation

Cytotherapy

Volumn 13, Issue 3, 2011, Pages 310-317

  Technau, Antje ^a   Froelich, Katrin ^a   Hagen, Rudolf ^a   Kleinsasser, Norbert ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adipose tissue derived stem cells; chondrogenic differentiation; human leukocyte antigen DR; immunogenicity; interferon

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; EPITOPE; GAMMA INTERFERON; HLA DR ANTIGEN; HLA G ANTIGEN; INTERLEUKIN 10; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA3;

ADIPOSE TISSUE; ADULT STEM CELL; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL TRANSDIFFERENTIATION; CHONDROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; UPREGULATION;

EID: 79951708094     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2010.504769     Document Type: Article

References (33)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal (Pubitemid 29282067)
2. Chamberlain G, Fox J, Ashton B, Middleton J. Concise Review: Mesenchymal stem cells: their phenotype, differentiation capacity immunological features and potential for homing. Stem Cells 2007;25:2739-49. (Pubitemid 350127858)
3. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringdén O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003;57:11-20 . (Pubitemid 38019084)
4. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-8. (Pubitemid 34059216)
5. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105: 1815-22. (Pubitemid 40223708)
6. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007;110:3499-3506. (Pubitemid 350159613)
7. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211-28. (Pubitemid 32295155)
8. Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramírez M, Bueren JA. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of graft-versus-host disease. Stem Cells 2006;24:2582-91 (Pubitemid 44674320)
9. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, et al. Immunomodulatory effect of human adipose tissue derived stem cells: comparison with bone marrow derived stem cells. Br J Hematol 2005;129:118-29. (Pubitemid 40524060)
10. Cui L, Yin S, Liu W, Li N, Zhang W, Cao Y. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E. Tissue Eng 2007;13: 1185-95. (Pubitemid 46986719)
11. Auguello A, Tasso R, Negrini SM, Cancedda R, Pennesi G. Cell therapy using allogeneic mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007;56:1175-86. (Pubitemid 46608642)
12. González MA, González-Rey E, Rico L, Büscher D, Delgado M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 2009;60:1006-19.
13. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31: 890-6. (Pubitemid 37211373)
14. Le Blanc K, Rasmussen I, Sundberg B, Götherström C, Hassan M, Uzunel M, et al. Treatment of severe graft-versushost disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-41. (Pubitemid 38586721)
15. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al. Mesenchymal stem cells for treatment of steroidresistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008;371:1579-86. (Pubitemid 351626841)
16. Reddy P, Arora M, Guimond M, Haynesworth SE, Ringdén O. GVHD: A Continuing Barrier to the Safety of Allogeneic Transplantation. Biol Blood Marrow Transplant 2008;15: 162-8.
17. Lefebvre V, Behringer RR, Crombrugghe C. L-Sox5, Sox6 and Sox9 control essential steps of the Chondrocyte differentiation pathway. Osteoarthr Cartil 2001;9:S69-75.
18. Lefebvre V, Dumitriu B, Penzo-Mendez A, Han Y, Pallavi B. Control of cell fate and differentiation by Sry-related highmobility- group box (Sox) transcription factors. Int J Biochem Cell Biol 2007;39:2195-214. (Pubitemid 47484275)
19. Han Y, Lefebvre V. L-Sox5 and Sox6 Drive Expression of the Aggrecan Gene in Cartilage by Securing Binding of Sox9 to a Far-Upstream Enhancer. Mol Cell Biol 2008; 28: 4999-5013.
20. Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+ CD25highFoxP3+ regulatory T cells. Stem Cells 2008;26: 212-22.
21. Selmani Z, Naji A, Gaiffe E, Obert, L., Tiberghien P, Rouas-Freiss N, et al. HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation 2009;87:62-6.
22. Meliga E, Strem BM, Duckers HJ, Serruys PW. Adiposederived cells. Cell Transplant. 2007;16:963-70.
23. Kilroy GE, Foster SJ, Wu X, Ruiz J, Sherwood S, Heifetz A, et al. Cytokine profi le of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and proinfl ammatory factors. J Cell Physiol 2007;212:702-9. (Pubitemid 47271882)
24. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal infl ammation. J Exp Med 1999;190:995-1004.
25. Stagg J, Pommey S, Eliopoulos N, Galipeau J. Interferongamma- stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood 2006;107: 2570-7. (Pubitemid 43348704)
26. Chan JL, Tang KC, Patel AP, Pierobon N, Ponzio NM, Rameshwar, P. Antigen-presenting property of mesenchymal stem cells occurs during narrow window at low levels of interferon-gamma. Blood 2006;107:4817-24. (Pubitemid 43882633)
27. Langer F, Gross AE. Immunogenicity of Allograft Articular Cartilage. J Bone Joint Surg Am 1974;56:297-304.
28. Niemeyer P, Krause U, Kasten P, Kreuz PC, Henle P, Südkam NP, et al. Mesenchymal stem cell-based HLA-independent cell therapy for tissue engineering of bone and cartilage. Curr Stem Cell Res Ther 2006;1:21-27.
29. Robinson D, Guetsky M, Halperin R, Schneider D, Nevo Z. Articular cartilage reconstruction using xenogeneic epiphyses slices. Cell Tissue Bank 2002;3:269-77. (Pubitemid 36950122)
30. Wang EC, Damrose EJ, Mendelsohn AH, Nelson SD, Shintaku IP, Ye M, et al. Distribution of class I and II human leukocyte antigens in the larynx. Otolaryngol Head and Neck Surg 2006;134:280-7. (Pubitemid 43187129)
31. Shipchandler T, Lorenz RR, Lee WT, Teker AM, Dan O, Strome M. Laryngeal Transplantation in the Setting of Cancer: A Rat Model. Laryngoscope 2008;118:2166-71.
32. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in an non-myeloablative setting. Blood 2006;108:2114-20. (Pubitemid 44395028)
33. Rasmusson I, Uhlin M, Le Blanc K, Levitsky V. Mesenchymal stem cells fail to trigger effector functions of cytotoxic T cells. J Leukoc Biol 2007;82:887-93. (Pubitemid 47511049)